A detailed history of Walleye Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Walleye Capital LLC holds 73,200 shares of LLY stock, worth $58.3 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
73,200
Previous 49,700 47.28%
Holding current value
$58.3 Million
Previous $45 Million 44.12%
% of portfolio
0.14%
Previous 0.08%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $26.4 Million - $32.8 Million
34,164 Added 181.35%
53,003 $47 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $832,150 - $1.04 Million
1,148 Added 6.49%
18,839 $17.1 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $2.72 Million - $3.64 Million
4,599 Added 35.13%
17,691 $13.8 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $6.88 Million - $8.11 Million
13,092 New
13,092 $7.63 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $30.3 Million - $40.5 Million
-86,350 Reduced 99.6%
348 $163,000
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $26.9 Million - $31.6 Million
86,698 New
86,698 $29.8 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $2.1 Million - $2.39 Million
7,075 Added 128.03%
12,601 $4.08 Million
Q2 2022

Aug 08, 2022

BUY
$278.73 - $327.27 $1.54 Million - $1.81 Million
5,526 New
5,526 $1.79 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $5.2 Million - $6.47 Million
-22,167 Closed
0 $0
Q4 2021

Mar 03, 2022

BUY
$224.85 - $279.04 $4.98 Million - $6.19 Million
22,167 New
22,167 $6.12 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $3.68 Million - $4.52 Million
-16,592 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $1.81 Million - $2.35 Million
-10,052 Reduced 37.73%
16,592 $3.81 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $1.24 Million - $1.61 Million
7,547 Added 39.52%
26,644 $4.98 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $2.37 Million - $3.13 Million
18,137 Added 1889.27%
19,097 $3.22 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $63,082 - $78,133
590 Added 159.46%
960 $126,000
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $18,834 - $21,984
170 Added 85.0%
370 $41,000
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $22,262 - $26,204
200 New
200 $26,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.